Chief Science Officer Beth Shapiro on bringing a species back to life in 7 "easy" steps 🧬 🦣 #woollymammoth #deextinction #womeninscience #tedx
Colossal Biosciences’ Post
More Relevant Posts
-
There's the science of today. And then there's the science bigger than any life or span of time. A science that's concerned not only with tomorrow, but also with 20 years, 300 years, 5,000 years from now. That science is Colossal. #deextinction #innovation #startup #technology #bioscience
For the first time in history, we are in control of a science with the power to reverse biodiversity loss.
-
Indigenous conservation should be indigenous-led. More to come.
I'm proud to announce the Colossal Biosciences Indigenous Council. Learn more: https://lnkd.in/gXnckJWq
-
-
United by a shared commitment to safeguard our planet's biodiversity, we are proud to announce the launch of our Indigenous Council. https://lnkd.in/gs5T6EeN
Indigenous-led Conservation | Colossal Biosciences
https://www.youtube.com/
-
We are excited to announce a monumental milestone in collaboration with Dr. Paul Ling and the Houston Zoo. The first mRNA vaccine for EEHV has been successfully administered to an elephant under human care. 🐘💉 This groundbreaking achievement marks a significant step forward in preventing EEHV-related deaths and showcases the power of scientific innovation in conservation. Together, we’re protecting the future of these magnificent creatures. 🌍🧬 #conservation #bioscience #innovation #savethelephants
-
This is the roadmap to de-extinction as presented by Beth Shapiro, Ph.D., at the Reverse the Red World Species Congress, along with Matt James, Stephen Frankenberg, Ph.D., and Thomas Hildebrandt, Ph.D. Tune in as they discuss biodiversity loss and Colossal's work in conservation. Watch our full panel here https://lnkd.in/gNvn6gNM
-
Thank you Chaitanya Gupta and Shivesh Sood for speaking with our Co-Founder George Church on the potential of de-extinction and reviving the Woolly Mammoth. 🦣 #deextinction #biotech #startups
Shivesh and I started The Deep Tea to unpack the latest developments in the deeptech startup space, For our first piece, we spoke with Prof George Church from the Harvard Medical School and Massachusetts Institute of Technology, a pioneer in the space and serial deeptech entrepreneur. Join us as he unpacks species revival, gene editing for climate conversation, the business of biotech, and what deeptech investors often overlook about innovation Happy to chat with folks and exchange ideas or learn from folks who are interested in the space - please DM! https://t.ly/B0ryv Wyss Institute at Harvard University Colossal Biosciences eGenesis, Inc. Dyno Therapeutics Editas Medicine Nebula Genomics Kern Systems Rejuvenate Bio Shape Therapeutics Inc. Manifold Bio Nabla Bio JURA Bio, Inc. Ginkgo Bioworks, Inc. Patch Therapeutics Pty Ltd
-
The importance of the work for saving Vaquitas cannot be understated. With so few left, we are proud to be supporting this conservation effort with Re:wild
The world’s rarest marine mammal is closer to extinction than ever before. This year’s Vaquita survey has been released - scientists spotted between 6-8 individuals, the lowest number ever reported. Collaboration between local communities and conservationists must be scaled up to ensure fishing practices can sustain locals without harming Vaquitas. Re:wild is committed to helping protect this species on the brink by aiming for a full Vaquita recovery, supporting Sea Shepherd Conservation Society and Vaquita-safe fishing gear and markets with Cetáceos, Acción y Transformación, Pesca ABC and Pronatura Noroeste. Positive steps ahead to save the Vaquita include: using improved acoustic detection devices, measuring Vaquita environmental DNA (eDNA) in the water column to detect and locate other individuals, expanding habitat protection, and training local youth to help monitor the last remaining Vaquitas. Learn more: https://lnkd.in/dw4DwfxR Credit : CONANP, SSCS, NMMF, Fabian Rodriguez
The Most Endangered Marine Mammal Still Exists. Here’s the Latest Count.
https://www.nytimes.com
